Evidence map›Paper›PMID 37485818›Full record

ArticleMolecular genetics & genomic medicine2023

Haplotypes of [-794(CATT)

Elizabeth Guevara-Gutiérrez, Marina Ramos-Súarez, Romina Angélica Villalobos-Ayala, Alberto Tlacuilo-Parra, José Francisco Muñoz-Valle, Victor Tarango-Martínez, Yeminia Valle, Jorge Ramón Padilla-Gutiérrez, José Manuel Rojas-Díaz, Emmanuel Valdés-Alvarado

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Association ofCurrent issues in molecular biology · 2024
    Article
  3. Haplotypes of [-794(CATT)Molecular genetics & genomic medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Elizabeth Guevara-GutiérrezDepartamento de Dermatología, Instituto Dermatológico de Jalisco "Dr. José Barba Rubio", Secretaría de Salud Jalisco, Zapopan, Mexico.ORCID 0000-0002-2911-1957
Marina Ramos-SúarezDepartamento de Dermatología, Instituto Dermatológico de Jalisco "Dr. José Barba Rubio", Secretaría de Salud Jalisco, Zapopan, Mexico.
Romina Angélica Villalobos-AyalaDepartamento de Dermatología, Instituto Dermatológico de Jalisco "Dr. José Barba Rubio", Secretaría de Salud Jalisco, Zapopan, Mexico.
Alberto Tlacuilo-ParraDivisión de Investigación, Unidad Médica de Alta Especialidad (UMAE), Hospital de Pediatría, Centro Médico Nacional de Occidente, IMSS, Guadalajara, Mexico.ORCID 0000-0003-0747-7189
José Francisco Muñoz-ValleInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.ORCID 0000-0002-2272-9260
Victor Tarango-MartínezDepartamento de Dermatología, Instituto Dermatológico de Jalisco "Dr. José Barba Rubio", Secretaría de Salud Jalisco, Zapopan, Mexico.
Yeminia ValleInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.ORCID 0000-0002-4940-022X
Jorge Ramón Padilla-GutiérrezInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.ORCID 0000-0002-0240-2797
José Manuel Rojas-DíazInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.
Emmanuel Valdés-AlvaradoInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.ORCID 0000-0001-6810-9203
Universidad de Guadalajara · MXSecretaría de Salud de Jalisco · MX

Funding

Universidad de Guadalajara PRODEP 2019
6 · The paper itself

Abstract

backgroundSome cytokines are strongly implicated in the development of squamous cell carcinoma (SCC) such as the Macrophage migration inhibitory factor (MIF). The haplotype -794 (CATT)

methodsThis study included 175 SCC patients and 175 age-sex-matched individuals as a reference group (RG) from western Mexico. Genomic DNA was extracted from peripheral blood leukocytes. Polymorphisms were genotyped by endpoint PCR and PCR-RFLP, and the determination of MIF serum levels was measured by ELISA. Clinical characteristics were evaluated by a group of dermatologists.

resultsAnalysis of [-794(CATT)

conclusionsOur findings suggest that 5C and 7G [-794(CATT)

Indexed as

Carcinoma, Squamous CellMacrophage Migration-Inhibitory FactorsSkin NeoplasmsGenetic Predisposition to DiseaseHaplotypesHumansIntramolecular OxidoreductasesMexicoPolymorphism, GeneticIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMIF protein, humancarcinoma, squamous cellcytokineshaplotypesmacrophage migration inhibition factorspolymorphism, genetic

Identifiers

PMID37485818
PMCPMC10655503
OpenAlexW4385186315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.